Synergistic co-delivery of diacid metabolite of norcantharidin and ABT-737 based on folate-modified lipid bilayer-coated mesoporous silica nanoparticle against hepatic carcinoma | SpringerLink
Understanding sensitivity to BH3 mimetics: ABT-737 as a case study to foresee the complexities of personalized medicine | Journal of Molecular Signaling | Full Text
Attacking cancer's Achilles heel: antagonism of anti‐apoptotic BCL‐2 family members - Opferman - 2016 - The FEBS Journal - Wiley Online Library
Why do BCL-2 inhibitors work and where should we use them in the clinic? | Cell Death & Differentiation
Targeting cell death signaling in colorectal cancer: Current strategies and future perspectives
Bim Upregulation by Histone Deacetylase Inhibitors Mediates Interactions with the Bcl-2 Antagonist ABT-737: Evidence for Distinct Roles for Bcl-2, Bcl-xL, and Mcl-1 | Molecular and Cellular Biology
ABT-737 overcomes Bcl-2 mediated resistance to doxorubicin–DNA adducts - ScienceDirect
Targeting Multiple Arms of the Apoptotic Regulatory Machinery | Cancer Research
Phosphorylation switches Bax from promoting to inhibiting apoptosis thereby increasing drug resistance | EMBO reports
ABT-737, an inhibitor of Bcl-2 family proteins, is a potent inducer of apoptosis in multiple myeloma cells | Leukemia
Enhanced anticancer effect of ABT-737 in combination with naringenin on gastric cancer cells
B Cell Lymphoma 2 and Cancer Therapy | Encyclopedia MDPI
Proposed model for the synergistic mechanism of ABT-737 and MG-132... | Download Scientific Diagram
Targeting BCL-2 in B-cell malignancies and overcoming therapeutic resistance | Cell Death & Disease
Synergistic Anticancer Effects of the 9.2.27PE Immunotoxin and ABT-737 in Melanoma
Drugs and Clinical Approaches Targeting the Antiapoptotic Protein: A Review
Inner Mitochondrial Membrane Disruption Links Apoptotic and Agonist-Initiated Phosphatidylserine Externalization in Platelets | Arteriosclerosis, Thrombosis, and Vascular Biology
Repurposing apoptosis-inducing cancer drugs to treat schistosomiasis | Future Medicinal Chemistry
The regulation of MCL-1 by Noxa expression and the mechanisms of... | Download Scientific Diagram
Targeting the intrinsic apoptosis pathway as a strategy for melanoma therapy - Mohana‐Kumaran - 2014 - Pigment Cell & Melanoma Research - Wiley Online Library
Frontiers | BH3 Mimetics for the Treatment of Prostate Cancer | Pharmacology
PROTACs are effective in addressing the platelet toxicity associated with BCL-XL inhibitors
Discovery of Marinopyrrole A (Maritoclax) as a Selective Mcl-1 Antagonist that Overcomes ABT-737 Resistance by Binding to and Targeting Mcl-1 for Proteasomal Degradation* - Journal of Biological Chemistry
Use of Human Cancer Cell Lines Mitochondria to Explore the Mechanisms of BH3 Peptides and ABT-737-Induced Mitochondrial Membrane Permeabilization
Mechanisms of potentiation of ABT-737 lethality by strategies targeting... | Download Scientific Diagram
